학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 4,474건 | 목록 1~20
Academic Journal
Lolli G; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Davini A; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Tabanelli V; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Sapienza MR; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Melle F; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Motta G; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Haematopathology Unit IRCCS Azienda Ospedaliero-Universitaria of Bologna Bologna Italy.; Del Corvo M; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Calleri A; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Vanazzi A; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Nierychlewska P; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Maraglino AME; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Castelli M; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Quattrocchi MC; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Chiarle R; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Department of Molecular Biotechnology and Health Sciences University of Turin Turin Italy.; Department of Pathology Boston Children's Hospital Boston Massachusetts USA.; Pileri S; Haemolymphopathology Division European Institute of Oncology IRCCS Milan Italy.; Tarella C; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Derenzini E; Oncohematology Division European Institute of Oncology IRCCS Milan Italy.; Department of Health Sciences University of Milan Milan Italy.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Academic Journal
Shustov, A, Cabrera, M E, Civallero, M, Hyeh Ko, Y, Manni, M, Skrypets, T, Horwitz, S M, de Souza, C A, Radford, J, Bobillo, S, Prates, M V, Ferreri, A J M, Spina, M, Vose, J M, Chiappella, A, Laszlo, D, Stelitano, C & Frederico, M 2021, 'ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project', Blood Advances, vol. 5, no. 3, 3, pp. 640-648. https://doi.org/10.1182/bloodadvances.2020001581
Academic Journal
Talarico G; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Franceschini A; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Raveane A; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Human Technopole, 20157, Milan, Italy.; Falvo P; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Mazzara S; Haematopathology Division, IRCCS, Istituto Europeo Di Oncologia, IEO, Milan, Italy.; Melle F; Haematopathology Division, IRCCS, Istituto Europeo Di Oncologia, IEO, Milan, Italy.; Motta G; Haematopathology Division, IRCCS, Istituto Europeo Di Oncologia, IEO, Milan, Italy.; Orecchioni S; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Tenore A; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Gregato G; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Poletti C; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Chiarle R; Haematopathology Division, IRCCS, Istituto Europeo Di Oncologia, IEO, Milan, Italy.; Pileri S; Haematopathology Division, IRCCS, Istituto Europeo Di Oncologia, IEO, Milan, Italy.; Mancuso P; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy.; Bertolini F; Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, MI, Italy. francesco.bertolini@ieo.it.; Onco-Tech Lab, European Institute of Oncology IRCCS and Politecnico di Milano, Milan, Italy. francesco.bertolini@ieo.it.
Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Academic Journal
Bouska A; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Zhang W; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Sharma S; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-Cell Malignancies, Oslo, Norway.; Shah RA; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Lone WG; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Soma MA; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Yang R; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.; Liu X; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.; Mehmood S; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Chawla RS; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Cappelli LV; Department of Pathology and Laboratory Medicine, Weil Cornell Medical College, New York, New York, USA.; Fiore D; Department of Pathology and Laboratory Medicine, Weil Cornell Medical College, New York, New York, USA.; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.; Gong Q; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.; Heavican-Foral TB; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Cannatella JJ; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Amador C; Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.; Arif A; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Smith LM; Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Lim ST; Division of Medical Oncology, National Cancer Centre Singapore/Duke-NUS Medical School, Singapore, Singapore.; Ong CK; Division of Medical Oncology, National Cancer Centre Singapore/Duke-NUS Medical School, Singapore, Singapore.; Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.; Du MQ; Department of Pathology, University of Cambridge, Cambridge, UK.; Perry AM; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.; de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Greiner TC; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Fu K; Department of Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Trøen G; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Vodák D; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Nakken S; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway.; Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.; Delabie J; Toronto General Hospital: University Health Network (UHN), University of Toronto, Toronto, Ontario, Canada.; Weinstock D; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Pileri S; European Institute of Oncology IRCCS, Milan, Italy.; Bologna University School of Medicine, Bologna, Italy.; Laginestra A; European Institute of Oncology IRCCS, Milan, Italy.; Kim K; Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Republic of Korea.; Program in Biomedical Science & Engineering, Inha University, Incheon, Republic of Korea.; Research Center for Controlling Intercellular Communication (RCIC), College of Medicine, Inha University, Incheon, Republic of Korea.; Pajvani U; Department of Medicine, Columbia University, New York, New York, USA.; Vose JM; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Weisenburger DD; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Horwitz SM; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Dave S; Department of Medicine, Duke University, Durham, North Carolina, USA.; Khoury J; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Inghirami G; Department of Pathology and Laboratory Medicine, Weil Cornell Medical College, New York, New York, USA.; Chan WC; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.; Iqbal J; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Pileri S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어